Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS‐ACTS Substudy

BACKGROUND: The efficacy, safety, and ease of use of rivaroxaban may reduce anticoagulation‐treatment burden and improve nonvalvular atrial fibrillation (NVAF) patient satisfaction compared with vitamin K antagonists (VKAs). HYPOTHESIS: Transitioning from a VKA to rivaroxaban improves treatment sati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Cardiol
Autores principales: Coleman, Craig I., Haas, Sylvia, Turpie, Alexander G.G., Kuhls, Silvia, Hess, Susanne, Evers, Thomas, Amarenco, Pierre, Kirchhof, Paulus, Camm, A. John
Formato: Artigo
Lenguaje:Inglês
Publicado: Wiley Periodicals, Inc. 2016
Materias:
Clinical Investigations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490868/
https://ncbi.nlm.nih.gov/pubmed/27362695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22565
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares